$14.2M
The grant funding will support the development and launch of a molecular tuberculosis testing system for developing countries.
L
LumiraDx
LumiraDx creates point-of-care diagnostic platforms for healthcare providers.
London, UK—Founded 2014
$14.2MTotal raised
LumiraDx develops point-of-care diagnostic testing platforms and assay menus for various healthcare applications.
Categories
Founders
RZ
Ron Zwanziger
CEO
DS
Dave Scott
JM
Jerry McAleer